Tocilizumab for rheumatoid and juvenile idiopathic arthritis

被引:13
作者
Bongartz, Tim [1 ,2 ]
机构
[1] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Div Rheumatol, Rochester, MN 55905 USA
关键词
D O I
10.1016/S0140-6736(08)60428-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:961 / 963
页数:3
相关论文
共 20 条
[1]   Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis [J].
Chung, Cecilia P. ;
Oeser, Annette ;
Avalos, Ingrid ;
Gebretsadik, Tebeb ;
Shintani, Ayumi ;
Raggi, Paolo ;
Sokka, Tuulikki ;
Pincus, Theodore ;
Stein, C. Michael .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (06)
[2]   Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate - Results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial [J].
Cohen, S ;
Hurd, E ;
Cush, J ;
Schiff, M ;
Weinblatt, ME ;
Moreland, LW ;
Kremer, J ;
Bear, MB ;
Rich, WJ ;
McCabe, D .
ARTHRITIS AND RHEUMATISM, 2002, 46 (03) :614-624
[3]   Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor α therapy -: Results from the British Society for Rheumatology Biologics Register [J].
Dixon, W. G. ;
Watson, K. D. ;
Lunt, M. ;
Silman, A. J. ;
Hyrich, K. L. ;
Symmons, D. P. M. .
ARTHRITIS AND RHEUMATISM, 2007, 56 (09) :2905-2912
[4]   The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial [J].
Emery, P ;
Fleischmann, R ;
Filipowicz-Sosnowska, A ;
Schechtman, J ;
Szczepanski, L ;
Kavanaugh, A ;
Racewicz, AJ ;
Van Vollenhoven, RF ;
Li, NF ;
Agarwal, S ;
Hessey, EW ;
Shaw, TM .
ARTHRITIS AND RHEUMATISM, 2006, 54 (05) :1390-1400
[5]   METHOTREXATE IN RESISTANT JUVENILE RHEUMATOID-ARTHRITIS - RESULTS OF THE USA-USSR DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
GIANNINI, EH ;
BREWER, EJ ;
KUZMINA, N ;
SHAIKOV, A ;
MAXIMOV, A ;
VORONTSOV, I ;
FINK, CW ;
NEWMAN, AJ ;
CASSIDY, JT ;
ZEMEL, LS .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (16) :1043-1049
[6]   Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? [J].
Gonzalez, A. ;
Kremers, H. Maradit ;
Crowson, C. S. ;
Ballman, K. V. ;
Roger, V. L. ;
Jacobsen, S. J. ;
O'Fallon, W. M. ;
Gabriel, S. E. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (01) :64-69
[7]   Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy - A randomized, placebo-controlled, 52-week trial [J].
Keystone, EC ;
Kavanaugh, AF ;
Sharp, JT ;
Tannenbaum, H ;
Hua, Y ;
Teoh, LS ;
Fischkoff, SA ;
Chartash, EK .
ARTHRITIS AND RHEUMATISM, 2004, 50 (05) :1400-1411
[8]   Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial [J].
Klareskog, L ;
van der Heijde, D ;
de Jager, JP ;
Gough, A ;
Kalden, J ;
Malaise, M ;
Mola, EM ;
Pavelka, K ;
Sany, J ;
Settas, L ;
Wajdula, J ;
Pedersen, R ;
Fatenejad, S ;
Sanda, M .
LANCET, 2004, 363 (9410) :675-681
[9]   Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig [J].
Kremer, JM ;
Westhovens, R ;
Leon, M ;
Di Giorgio, E ;
Alten, R ;
Steinfeld, S ;
Russell, A ;
Dougados, M ;
Emery, P ;
Nuamah, IF ;
Williams, GR ;
Becker, JC ;
Hagerty, DT ;
Moreland, LW .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20) :1907-1915
[10]   Etanercept in children with polyarticular juvenile rheumatoid arthritis. [J].
Lovell, DJ ;
Giannini, EH ;
Reiff, A ;
Cawkwell, GD ;
Silverman, ED ;
Nocton, JJ ;
Stein, LD ;
Gedalia, A ;
Ilowite, NT ;
Wallace, CA ;
Whitmore, J ;
Finck, BK .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (11) :763-769